NURS FPX 6200 Assessment 2 Care Setting SOAR Analysis

You are currently viewing NURS FPX 6200 Assessment 2 Care Setting SOAR Analysis

NURS FPX 6200 Assessment 2
Free Download

Care Setting SOAR Analysis

Student name

Capella University

NURS-FPX 6200

Professor Name

Submission Date

The SOAR (Strengths, Opportunities, Aspirations, and Results) analysis is an efficient model for analyzing the performance of the organization and the aspects that need to be improved within the healthcare facility. Compared to conventional SWOT analyses, which only determine the strengths and opportunities to pursue the aspirational goals and measurable outcomes, SOAR has enabled the application of strengths and opportunities to pursue the aspirational goals and measurable outcomes (Cole et al., 2022).

This approach is especially useful regarding critical issues, including medication reconciliation after discharge, which is one of the primary factors to consider when it comes to patient safety and hospital readmission rates. This will address strengths and opportunities of the care setting, will consider zones to improve on, and will guide methodologies to improve medication reconciliation processes after discharge to Mayo Clinic.

Leadership Structure and Promotion of Quality and Safety Goals

The care setting has a leadership structure that is very important in advancing quality and safety objectives, especially in medication reconciliation after discharge within the Mayo Clinic. The organizational model entails the collaborative model of leadership, which is an interdisciplinary teamwork that guarantees an ideal communication process among nurses, pharmacists, and physicians. The priorities of leaders are continuous education and training on medication safety that help staff to identify and eliminate possible mistakes (Montaleytang et al., 2021).

The leadership also creates an air of accountability through the implementation of evidence-based protocols and the promotion of discrepancies being reported without fear of repercussions. The quality audit and debriefs conducted by the leadership members regularly determine the results of the process to make sure that they are in alignment with the overall safety organizational goals. This model is systematic, which facilitates the intent to participate in patient-centered care and mitigate the risks of medication error after discharge.

Pursuing Improvements in Medication Reconciliation Post-Discharge

To enhance medication reconciliation after discharge in the Mayo Clinic, the care environment may use the integration of digital tools to enhance the communication process between hospital personnel and outpatient caregivers. Probably, leaders should consider the potential to extend the utilization of patient portals to allow patients to become more involved in their care by delivering medication prescriptions and instructions (Daliri et al., 2021). In addition, pharmacist staffing can be improved in the discharge planning procedure to perform proper medication reviews and minimize discrepancies.

It might be helpful to create follow-up measures, such as post-discharge phone calls by the nursing staff members, to get some understanding and resolve any possible medication-related problems immediately. These enhancements of care environments will advance the care setting to lessen adverse drug events, enhance patient safety, and enhance health outcomes, which are aligned with the organizational objectives of quality enhancement.

Strengths of the Organization in Promoting Quality and Safety

The Mayo Clinic has several strengths that play in favor of the quality and safety of medication reconciliation after discharge. The method is multidisciplinary, which enables nurses, pharmacists, and physicians to work together, limiting the possibilities of medication errors. The elements of standard medication reconciliation procedures are applied to ensure consistency and reliability in the discharge processes (Marinović et al., 2021).

Moreover, the organization also spends efforts on the education of staff regarding the field of medication safety. The next step in the enhanced technological system development, like electronic health records (EHRs), enhances the accuracy of the medication reconciliation process with the help of improved communication and patient data accessibility. Finally, the culture that the leadership has nurtured is a culture of constant improvement, whereby the staff are proactively encouraged to take a closer look at safety issues.

Using Strengths to Achieve Organizational Goals

The Mayo has some strengths that can be optimized in the realization of its objectives in the improvement of medication reconciliation after discharge. Among the extensions would be to expand the multidisciplinary team by adding a team to provide follow-up care and maintain continuity of care. By relying on modern technology, such as patient portals and automated reminders, the organization will be able to improve patient interaction and communication (Costello et al., 2023).

The skills of the workforce can be retained by increasing staff education programs to reflect the more recent trends in medication safety. The culture of accountability is capable of supporting the creation of new creative interventions to decrease negative drug events, e.g., the incorporation of pharmacist-based discharge assessments. As the organization continues to add to its strengths, patient safety can be enhanced, readmission rates can be decreased, and quality improvement objectives can be achieved.

Area of Concern Identified in the SOAR Analysis

The issues in the SOAR analysis found in one area are the lack of consistency in following up the patients after discharge, which affects medication reconciliation efficacy. It has faith in patient-centered care and safety, yet overall, there may be lapses in the post-discharge communication, leading to medication errors, adverse drug events, or nonadherence (Nymoen et al., 2022).

The Mayo Clinic, in particular, needs it as part of its mission of providing quality and safe care and its vision of minimizing avoidable readmissions. The challenge has been caused by the lack of staffing and time to follow up on care, thus providing a hindrance to successful medication management. Addressing this concern is also in line with the values of accountability and continuous improvement of the organization because it is important to patient safety and outcomes.

Proposing Improvements in the Area of Concern

To solve the issue with the non-uniformity in follow-up, the Mayo Clinic may introduce a specific post-discharge follow-up program facilitated by pharmacists or specially trained nurses. The post-discharge telephone calls or telehealth visits 48 to 72 hours afterward may be considered as one of the elements of this program, as medications may be reviewed, and the concerns of patients are addressed. To enhance communication and adherence, it is possible to exploit technology, including automated medication reminders or a patient portal (Rosenstengle et al., 2022).

Also, this initiative would be sustainable in case the staff education about the necessity of post-discharge follow-up and resource reallocation in support of this should be enhanced. This would further improve the medication reconciliation process, reduce medication-related complications, and be in line with the mission statement of the organization to provide safe and high-quality care.

Reaching Goals to Improve Quality and Safety

The Mayo Clinic has the chance to achieve its objectives to enhance the quality and safety of medication reconciliation post-discharge through its dedication to patient-centered care and innovation. To avoid medication errors, the organization can address the issue of complexifying the medication reconciliation processes by enhancing communication between multidisciplinary teams, such as pharmacists, nurses, and physicians. Technology should be extended and applied to enhance the accuracy and uniformity of conveying the medication instructions to the patients and their carers, this is through Electronic Health Records (EHRs) and patient portals (Mozafarian et al., 2025).

Moreover, the evidence-based practice at the Mayo Clinic can also drive the standardization of the discharge protocols to minimize the variation in the case of medication lists. This must be an ongoing process of patient education that must be modified to the patient’s needs following discharge, and chances of improving patient compliance with medication, and hence patient safety and quality.

Strategic Initiatives Supporting Organizational Aspirations

The Mayo Clinic can adopt several strategic measures to help it achieve its dreams of minimizing readmissions and enhancing medication safety. One such initiative is the establishment of a pharmacist-led discharge review program, where all medications and their clarifications to the patient are achieved at the hospital. The second one is to make telehealth services, such as virtual follow-up appointments involving medication management within 72 hours following the discharge (Stuijt et al., 2021). The automated alerts in the EHR system could also help the clinic in detecting potential medication interactions or medication duplicates in the medication list that would be detected by the providers.

Another opportunity to improve patient engagement to increase the adherence level is mobile applications or portals that may assist patients with medication reminders and educational materials. These efforts are in line with the mission and vision of the Mayo Clinic in delivering the best in patient care and safety.

Accomplishing Meaningful Quality Outcomes Through Leadership Structure

A combined and patient-centered leadership framework is effective in attaining all the meaningful quality outcomes in medicine reconciliation post-discharge at the Mayo Clinic. In this case, leadership encourages teamwork between the interdisciplinary teams, among the pharmacists, nurses, and physicians, which will help identify the medications effectively and before discharge. Leaders underline the necessity to use evidence-based procedures such as standardized medication reconciliation checklists to achieve uniformity and reduce the occurrence of errors (Daliri et al., 2020).

In addition, the leadership fosters a sense of responsibility and quality enhancement in which the employees are motivated to report anomalies and engage in quality enhancement projects. Leaders constantly review progress and make evidence-based decisions to seal the gaps and introduce additional targeted interventions to improve the results. Through such a systematic practice, the practice will be consistent with the mission of the Mayo Clinic, which aims to deliver high-quality, safe, and patient-centered care.

Evidence-Based Practices Supporting Leadership’s Approach

The leadership at the Mayo Clinic incorporates evidence-based practice to improve the evidence-based medication reconciliation results. Pharmacist-based discharge intervention can decrease medication errors and adverse drug events, and it can be connected to an interdisciplinary approach in the clinic. Electronic health records (EHRs) containing the automated alert system facilitate the correct communication and warn of the potential for medication interaction.

It is also useful in helping studies to emphasize the importance of patient education programs that can result in medication adherence and reduce readmissions (Daliri et al., 2021). The following evidence-based strategies developed by the Mayo Clinic leadership concerning the reliability and safety of medication reconciliation procedures are based on the vision of the Mayo Clinic that involves delivering excellence in its healthcare delivery.

Relevant Skills and Leadership Characteristics for Quality and Safety Improvement

To implement quality and safety improvement initiatives, including but not limited to improving medication reconciliation after discharge in the Mayo Clinic, a leader needs to have certain skills and attributes. There must be good communication skills to make sure that an interdisciplinary team of nurses, pharmacists, and physicians collaborate properly. During the process of discharges, patients’ needs should be listened to with empathy and concern. It also involves the ability of leaders to be flexible and resolve issues like medication list discrepancies or lack of follow-up care.

Visionary leadership is essential to empower teams to make them focus on the vision of the organization to deliver high-quality, patient-centered care (Daliri et al., 2020). In addition, accountability and learning culture will also assist in avoiding complacency among the staff and make them strive to not only enhance processes, but also practice on the evidence. Such are important leadership qualities to facilitate significant change in medication safety and attainment of organizational objectives.

Areas of Uncertainty or Knowledge Gaps

Regardless of the strengths of the Mayo Clinic, there are areas of uncertainty in post-discharge medication reconciliation. One of the gaps is that there is no available exhaustive data about patient management of medication post-discharge, and therefore, it is impossible to determine certain obstacles to adherence. Besides, there is a significant uncertainty on the most successful means of involving patients in follow-up care, particularly among patients with low health literacy (Mozafarian et al., 2025).

The other knowledge gap defines the way to optimize technology, including EHRs, in this environment, to assist in medication reconciliation processes. Also, interventions led by pharmacists are effective, although it is doubtful how such programs can be scaled and how effective they could be within all departments. These gaps will require research and pilot programs to assist in improving medication safety and ensuring that the Mayo Clinic attains its objectives regarding quality improvement.

Conclusion

To sum up, the SOAR analysis offers great data on the strengths, opportunities, aspirations, and outcomes that may be used to improve medication reconciliation after discharge. Collaborative leadership structure of an organization, evidence-based practice, and patient-centered care can help healthcare leaders to fill the gaps and uncertainties to achieve better safety and quality outcomes.

The mission of the organization is to offer quality care and minimize medication-related complications, and strategic initiatives align with this mission, such as pharmacist-led intervention and better follow-up procedures. Lastly, the results can be used to provide a foundation to develop a comprehensive strategic plan for improving patient safety and healthcare provision.

For 3rd assessment of NURS FPX6200, visit: NURS FPX 6200 Assessment 2

Step By Step Instructions to write
NURS-FPX6200 Assessment 2

For instructions to complete NURS FPX 6200 Assessment 2: Care Setting SOAR Analysis, contact with onlineclassservices.com.

References for

NURS FPX6200 Assessment 2

The References for NURS FPX 6200 Assessment 2 are given below

Costello, J., Barras, M., Foot, H., & Cottrell, N. (2023). The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. Exploratory Research in Clinical and Social Pharmacy11, 12. https://doi.org/10.1016/j.rcsop.2023.100305

Cole, M. L., Stavros, J. M., Cox, J., & Stavros, A. (2022). Measuring strengths, opportunities, aspirations, and results: Psychometric properties of the 12-item SOAR scale. Frontiers in Psychology13(13). https://doi.org/10.3389/fpsyg.2022.854406

Daliri, S., Bouhnouf, M., van de Meerendonk, H. W. P. C., Buurman, B. M., Scholte Op Reimer, W. J. M., Kooij, M. J., & Karapinar-Çarkit, F. (2021). Longitudinal medication reconciliation at hospital admission, discharge, and post-discharge. Research in Social & Administrative Pharmacy17(4), 677–684. https://doi.org/10.1016/j.sapharm.2020.05.022

Daliri, S., Boujarfi, S., el Mokaddam, A., Scholte op Reimer, W. J. M., ter Riet, G., den Haan, C., Buurman, B. M., & Karapinar-Çarkit, F. (2020). Medication-related interventions delivered both in hospital and following discharge: A systematic review and meta-analysis. British Medical Journal30(2), 146–156. https://doi.org/10.1136/bmjqs-2020-010927

Montaleytang, M., Correard, F., Spiteri, C., Boutier, P., Gayet, S., Honore, S., Villani, P., & Daumas, A. (2021). Medication reconciliation in the geriatric unit: Impact on the maintenance of post-hospitalization prescriptions. International Journal of Clinical Pharmacy43(5), 1183–1190. https://doi.org/10.1007/s11096-021-01229-y

Mozafarian, B., Farzanegan, F., & Sepehri, M. (2025). A post-discharge process framework to improve follow-up, medication reconciliation, patient satisfaction, and readmission rate in a pediatric hospitalhttps://conference.modares.ac.ir/files/site1/rds_journals/2682/article-2682-4985.pdf

Nymoen, L. D., Flatebø, T. E., Moger, T. A., Øie, E., Molden, E., & Viktil, K. K. (2022). Impact of systematic medication review in the emergency department on patients’ post-discharge outcomes—A randomized controlled clinical trial. Public Library of Science17(9), 12. https://doi.org/10.1371/journal.pone.0274907

Rosenstengle, C., Kripalani, S., & Rahimi, R. S. (2022). Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care. Journal of Hospital Medicine17(S1). https://doi.org/10.1002/jhm.12896

Stuijt, C. C. M., Bekker, C. L., van den Bemt, B. J. F., & Karapinar, F. (2021). Effect of medication reconciliation on patient-reported potential adverse events after hospital discharge. Research in Social and Administrative Pharmacy17(8), 1426–1432. https://doi.org/10.1016/j.sapharm.2020.10.012

Choose Best Professor for

NURS FPX6200

Alkeisha Mims –> DNP, MHA, MSN 

Lauren Roberts –> DNP, MSN, MBA, BSN